2026 Medical-Dental Global AI Summit
Pitch Day
The Premier Stage for Global Integrated Health, Med-Tech
and AI-Driven Innovation ► Warwick Hall
Friday, June 26, 2026
Pitch Day
The Premier Stage for Global Integrated Health, Med-Tech
and AI-Driven Innovation ► Warwick Hall
Friday, June 26, 2026
Through expert keynotes, Shark Tank–style pitches, rapid-fire innovation sessions, and exclusive matchmaking opportunities, Pitch Day offers a front-row view of the most promising solutions in AI, medical devices, precision diagnostics, digital health, and integrated care ecosystems.
Designed for those who want to anticipate industry shifts, identify high-value opportunities, and contribute to the future of global integrated healthcare, this event is where the next decade of innovation begins.
Session Schedule – Pitchers

Dr. Cari Green
Good Mood Company Ltd
(AI driven)
The Good Mood Co is a cutting-edge AI-powered platform dedicated to transforming personalised health and wellness. Our mission is to empower individuals to optimise their healthspan through innovative, science-backed solutions.
Speaker Bio:
Dr. Cari Green expertise is in functional medicine and digital technology. Dr. Green has long-standing expertise as a health consultant with clients in North America, Europe, and the Middle East and currently holds a license to practice medicine in Germany and Croatia as well as full GMC registration in the UK. She did her MD at the University of Zagreb. Cari received her B.Mus (piano) from the Brandon University School of Music and studied dance in the B.F.A. program at York University in Toronto.

Dr. May Rezai
Mirzyme Therapeutics
(Biotech but world excellence)
MirZyme Therapeutics offers the end-to-end preeclampsia solution. It is an early-stage clinical women’s health biopharmaceutical company.
Speaker Bio:
Dr. May Rezai is a biomedical scientist and the lead scientist at Mirzyme Biotech Ltd, where she leads the development of a groundbreaking therapeutic programme targeting Preeclampsia, one of the most dangerous complications of pregnancy worldwide. Her work focuses on the molecular biology of placental dysfunction and the development of disease-modifying therapies designed to address the root cause of the condition. Her research represents a significant step toward the first true therapeutic solution for preeclampsia.

Mr. Nathan Nagel
Global Muslim Weight Management Group Ltd (AI driven)
Global Muslim Weight Management Group Ltd combines a human coaching service to support Muslims to manage their weight with an AI Clinical Trail matching system.
Speaker Bio:
Mr. Nathan Nagel is a healthcare entrepreneur with 20 years’ experience leading companies. He is the CEO of the Global Muslim Weight Management Group Ltd, an external advisory board member of the UCL Global Business School of Health and the UK lead for the Society of Physician Entrepreneurs. He holds a BSc in Biomedical Science, an MA in Business Administration, and postgraduate certificates from the LBSA and Harvard Medical School.

Dr. Soufiane Z. Azdad
Algoscope
(AI driven)
Algoscope uses leading edge AI and automation to make the diagnostic process between surgery and pathology easier and more reliable.
Speaker Bio:
Dr. Soufiane Zakaria Azdad, M.D., is a pathologist, inventor, and healthcare entrepreneur. He is the co-founder and CEO of Algoscope, a medical technology company developing advanced tools to modernise laboratory medicine and digital pathology workflows. With experience spanning clinical medicine, medical device regulation, and high-technology engineering, Dr. Azdad focuses on improving the pre-analytical stages of pathology to enhance diagnostic accuracy, efficiency, and patient safety.

Dr. Myriam Guiral
Kunto
Reduce rehospitalizations and maximize therapeutic adherence through proprietary Al
Speaker Bio:
Dr. Myriam Guiral is a distinguished scientist specializing in the molecular mechanisms of life. With a PhD in Biochemistry and Molecular Biology, her career is defined by a rigorous pursuit of understanding cellular functions and their implications for human health. Dr. Guiral has dedicated years to bridging the gap between fundamental research and clinical application, contributing to high-impact studies that advance our knowledge of protein interactions and enzymatic pathways.

Dr. William Kilgallon
HaemAnalytica
Multi-parameter assays and AI-based phenotyping, enabling insightful platelet analysis to de-risk clinical trials and enhance drug development.
Speaker Bio:
Dr. William has over 30 years of experience in the Pharmaceutical, Biotechnology and Diagnostic sectors encompassing SME and multi-national corporations. He has worked at senior vice president level covering Europe, USA, Latin America, Asia Pacific and Japan. William has completed a wide range of entrepreneurial projects including management buyouts, business turnarounds, trade sales and the securing of investments in the Biotech sector.
Key Opinion Leader Lectures (TED Talk Style)

Dr. Natasha Dole
- MBChB (Stell), DipPEC (SA), FRCEM (UK)
- Digital & AI Lead | Milton Keynes University Hospital NHS Foundation Trust
Why 95% of AI innovations don’t work in A&E
- Understand why AI fails in A&E due to real-world complexity and workflow mismatch.
- Recognize importance of clinician involvement, safety, and human oversight in AI adoption.
- Identify risks of bias, hallucinations, and unsafe outputs in AI systems.
Speaker Bio:
Dr. Natasha Dole is a distinguished Emergency Medicine Consultant and the Digital & AI Lead at Milton Keynes University Hospital (MKUH) NHS Foundation Trust. She bridges the gap between frontline clinical practice and advanced data architecture. In her leadership role, Dr. Dole focuses on the clinical operationalization of AI, ensuring that technical innovation translates into safe, bedside application. Her work prioritizes rigorous clinical governance, adhering to peer-reviewed standards and established pathophysiology to maintain absolute data integrity. By streamlining “street-to-specialist” digital pathways, she is de fining a new standard for high-fidelity, “cold, clinical” health technology within the NHS.
What You’ll Experience
Key Opinion Leader Lectures (TED Talk Style)
Shark Tank Startup Pitch Arena
Rapid-Fire Innovation Contest
Expert Panel on the Future of Integrated Health
Investor Matchmaking & Elite Networking
Emerging Tech Showcase & Demo Stations
Who Should Attend?
For Startups
Pitch Day is designed for ambitious pre-Series A teams ready to raise capital and gain global visibility. It’s the ideal stage for founders building technologies with strong clinical relevance and scalable potential.
You’ll benefit if you’re looking to:
- raise $250K–$2M
- present to international investors
- validate your innovation with decision-makers
- accelerate traction, partnerships, and adoption
For Investors
You’ll gain access to:
- high-quality deal flow
- direct founder engagement
- pitch decks & due diligence materials
- 1:1 meetings aligned with your investment thesis
For Clinicians & Key Opinion Leaders
You’ll discover innovations in:
- AI-driven clinical workflows
- salivary and precision diagnostics
- sleep & oral–systemic health
- remote monitoring and early detection
Executives and Innovators
You’ll identify opportunities for:
- partnerships and integrations
- product development pipelines
- acquisition targets
- technology scouting and market intelligence
